Lagos, October 2025 — Leading Nigerian law firm Jackson, Etti & Edu (JEE) has convened an in-depth Industry Chat to examine opportunities and regulatory challenges shaping the country’s rapidly evolving pharmaceutical sector.
The session, organized by the firm’s Health & Pharmaceuticals Sector Practice, focused on two key themes: “Unlocking Opportunities: Government Incentives Powering Nigeria’s Pharma Industry” and “Pharmaceutical Law & Regulation: Compliance Across the Value Chain.”
Facilitated by senior team members Ebuka Obidigwe and Toluwalase Oliver-Jude, the discussions shed light on a range of fiscal incentives available to players in the sector, including tax holidays, import duty exemptions, and access to low-interest financing. The conversation also tackled critical compliance issues such as NAFDAC approvals, NHIA requirements, drug distribution controls, intellectual property protection, and efforts to combat counterfeit medicines.
Chinyere Okorocha, Head of Sectors at Jackson, Etti & Edu and a leading health and pharmaceutical law expert, emphasized the importance of the dialogue in bridging gaps between regulation and industry growth. She noted that the discussions were “engaging and interactive, highlighting both the opportunities and regulatory pitfalls across the pharmaceutical value chain.”
Okorocha underscored the increasingly strategic role that lawyers play in helping pharmaceutical companies navigate Nigeria’s regulatory landscape. “We support clients through compliance audits, regulatory structuring, and transactional advice, enabling them to manage risks, meet obligations, and unlock growth opportunities,” she said.
She praised her team’s dedication and expertise, adding that JEE remains committed to guiding clients through the complex interplay of policy, law, and innovation that defines the country’s health and pharmaceutical sectors.
The event comes at a time when Nigeria’s pharmaceutical industry is seeking to expand local manufacturing capacity, attract investment, and strengthen regulatory frameworks to improve access to safe and affordable medicines.
